We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BASFY plans to launch Nemasphere in the United States and Brazil from 2028.
Nemasphere offers up to 90% nematode control and 10% yield improvement.
BASFY secured key export approvals and plans to pair Nemasphere with Enlist E3.
BASF SE (BASFY - Free Report) is strengthening its Agricultural Solutions portfolio with the introduction of Nemasphere technology, a nematode-resistant biotechnology trait designed to protect soybean crops against damaging nematodes. The commercialization is planned in the United States and Brazil from 2028. This move is aligned with the Seed Solutions business’ growth strategy, with the technology carrying peak sales potential of more than 300 million euros.
Nemasphere introduces a first-of-its-kind biotech trait that provides resistance against key plant-parasitic soybean nematodes. The technology offers up to 90% control and helped improve average yields by up to 10% in field trials. As nematodes cause an estimated $4.5 billion in annual crop losses in Brazil and the United States, the innovation addresses a significant challenge and offers farmers access to crucial technologies.
The latest import authorization for Nemasphere-containing soybeans in the European Union completes the regulatory approvals currently required in key export markets. BASFY plans to stack the technology with the Enlist E3 soybean trait in its launch varieties.
This innovation reinforces BASFY's growth potential in Seed Solutions. Its scalable market demand will create additional revenue streams and strengthen the company's competitive position in agricultural technology.
BASFY's shares have gained 21.7% in the past year compared with the industry’s 23.5% growth.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Element Solutions Inc. (ESI - Free Report) and Worthington Steel, Inc. (WS - Free Report) .
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $26.54 per share, indicating an 86.1% year-over-year surge. RS’shares have gained 58.3% over the past year.
The Zacks Consensus Estimate for ESI’s 2026 earnings is pegged at $1.85 per share, indicating a year-over-year rise of 24.2%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 6%.
The Zacks Consensus Estimate for WS’ current fiscal-year earnings is pinned at $4.07 per share. WS’shares have gained 24% over the past year.
Image: Bigstock
BASF's Nemasphere Technology Boosts Seed Solutions Growth Prospects
Key Takeaways
BASF SE (BASFY - Free Report) is strengthening its Agricultural Solutions portfolio with the introduction of Nemasphere technology, a nematode-resistant biotechnology trait designed to protect soybean crops against damaging nematodes. The commercialization is planned in the United States and Brazil from 2028. This move is aligned with the Seed Solutions business’ growth strategy, with the technology carrying peak sales potential of more than 300 million euros.
Nemasphere introduces a first-of-its-kind biotech trait that provides resistance against key plant-parasitic soybean nematodes. The technology offers up to 90% control and helped improve average yields by up to 10% in field trials. As nematodes cause an estimated $4.5 billion in annual crop losses in Brazil and the United States, the innovation addresses a significant challenge and offers farmers access to crucial technologies.
The latest import authorization for Nemasphere-containing soybeans in the European Union completes the regulatory approvals currently required in key export markets. BASFY plans to stack the technology with the Enlist E3 soybean trait in its launch varieties.
This innovation reinforces BASFY's growth potential in Seed Solutions. Its scalable market demand will create additional revenue streams and strengthen the company's competitive position in agricultural technology.
BASFY's shares have gained 21.7% in the past year compared with the industry’s 23.5% growth.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Element Solutions Inc. (ESI - Free Report) and Worthington Steel, Inc. (WS - Free Report) .
RS currently sports a Zacks Rank #1 (Strong Buy), while ESI and WS carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $26.54 per share, indicating an 86.1% year-over-year surge. RS’shares have gained 58.3% over the past year.
The Zacks Consensus Estimate for ESI’s 2026 earnings is pegged at $1.85 per share, indicating a year-over-year rise of 24.2%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 6%.
The Zacks Consensus Estimate for WS’ current fiscal-year earnings is pinned at $4.07 per share. WS’shares have gained 24% over the past year.